Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 9,088 | 7,849 | 7,310 | 0 |
| Operating Income | -9,088 | -7,849 | -7,310 | N/A |
| Other Income | 145 | 3 | 370 | 0 |
| Pre-tax Income | -8,943 | -7,846 | -6,940 | 0 |
| Net Income Continuous | -8,943 | -7,846 | -6,940 | N/A |
| Net Income | $-8,943 | $-7,846 | $-6,940 | $N/A |
| EPS Basic Total Ops | -8.08 | -7.50 | -7.62 | N/A |
| EPS Basic Continuous Ops | -6.69 | -6.62 | -6.81 | N/A |
| EPS Diluted Total Ops | -8.08 | -7.50 | -7.62 | N/A |
| EPS Diluted Continuous Ops | -6.69 | -6.62 | -6.81 | N/A |
| EBITDA(a) | $-8,629 | $-7,646 | $-7,136 | $N/A |